[Skip to Navigation]
Medical News & Perspectives
March 18, 2020

Cardiovascular Corner—Stable Coronary Artery Disease, An LDL “Vaccine,” and Anti-inflammatories

JAMA. 2020;323(13):1233-1234. doi:10.1001/jama.2019.20983

A trial to answer an important clinical question, along with studies of novel and repurposed drugs, made news at the American Heart Association’s flagship conference in Chicago late last year.

The hotly anticipated results from a major trial should help to resolve a common clinical question: should patients with significant but stable coronary artery disease begin treatment with medication and lifestyle changes alone or will undergoing an invasive procedure, like stent placement or bypass surgery, along with medical therapy produce better outcomes?